Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   282.71 (-1.47%)
AAPL   144.35 (-2.54%)
MSFT   241.78 (-2.31%)
META   108.74 (-2.40%)
GOOGL   96.00 (-1.50%)
AMZN   93.92 (+0.55%)
TSLA   182.61 (-0.14%)
NVDA   158.50 (-2.58%)
NIO   10.11 (-0.59%)
BABA   75.84 (+0.45%)
AMD   73.19 (-2.60%)
T   18.84 (-1.46%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.75 (-2.34%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.92 (-0.20%)
PFE   49.60 (+0.79%)
NFLX   281.33 (-1.47%)
QQQ   282.71 (-1.47%)
AAPL   144.35 (-2.54%)
MSFT   241.78 (-2.31%)
META   108.74 (-2.40%)
GOOGL   96.00 (-1.50%)
AMZN   93.92 (+0.55%)
TSLA   182.61 (-0.14%)
NVDA   158.50 (-2.58%)
NIO   10.11 (-0.59%)
BABA   75.84 (+0.45%)
AMD   73.19 (-2.60%)
T   18.84 (-1.46%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.75 (-2.34%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.92 (-0.20%)
PFE   49.60 (+0.79%)
NFLX   281.33 (-1.47%)
QQQ   282.71 (-1.47%)
AAPL   144.35 (-2.54%)
MSFT   241.78 (-2.31%)
META   108.74 (-2.40%)
GOOGL   96.00 (-1.50%)
AMZN   93.92 (+0.55%)
TSLA   182.61 (-0.14%)
NVDA   158.50 (-2.58%)
NIO   10.11 (-0.59%)
BABA   75.84 (+0.45%)
AMD   73.19 (-2.60%)
T   18.84 (-1.46%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.75 (-2.34%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.92 (-0.20%)
PFE   49.60 (+0.79%)
NFLX   281.33 (-1.47%)
QQQ   282.71 (-1.47%)
AAPL   144.35 (-2.54%)
MSFT   241.78 (-2.31%)
META   108.74 (-2.40%)
GOOGL   96.00 (-1.50%)
AMZN   93.92 (+0.55%)
TSLA   182.61 (-0.14%)
NVDA   158.50 (-2.58%)
NIO   10.11 (-0.59%)
BABA   75.84 (+0.45%)
AMD   73.19 (-2.60%)
T   18.84 (-1.46%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.75 (-2.34%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.92 (-0.20%)
PFE   49.60 (+0.79%)
NFLX   281.33 (-1.47%)
NASDAQ:CLBT

Cellebrite DI - CLBT Stock Forecast, Price & News

$4.56
-0.08 (-1.72%)
(As of 11/28/2022 03:59 PM ET)
Add
Compare
Today's Range
$4.45
$4.64
50-Day Range
$3.92
$4.95
52-Week Range
$3.80
$8.95
Volume
2,138 shs
Average Volume
200,303 shs
Market Capitalization
$864.80 million
P/E Ratio
5.56
Dividend Yield
N/A
Price Target
$8.83

Cellebrite DI MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.71 Rating Score
Upside/​Downside
92.4% Upside
$8.83 Price Target
Short Interest
Bearish
4.15% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.22mentions of Cellebrite DI in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
150.00%
From $0.08 to $0.20 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.03 out of 5 stars

Business Services Sector

172nd out of 327 stocks

Prepackaged Software Industry

121st out of 221 stocks

CLBT stock logo

About Cellebrite DI (NASDAQ:CLBT) Stock

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.

Receive CLBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter.

CLBT Stock News Headlines

Cellebrite Announces Third Quarter 2022 Results
Earnings Preview For Cellebrite DI
Lisa Cole Joins Cellebrite as Chief Marketing Officer
Cellebrite DI Ltd.
See More Headlines
Receive CLBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter.

CLBT Company Calendar

Today
11/28/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/15/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CLBT
Employees
900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$8.83
High Stock Price Forecast
$10.50
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+93.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.71
Research Coverage
7 Analysts

Profitability

Net Income
$71.40 million
Pretax Margin
62.66%

Debt

Sales & Book Value

Annual Sales
$246.25 million
Cash Flow
$0.21 per share
Book Value
($0.39) per share

Miscellaneous

Free Float
N/A
Market Cap
$864.80 million
Optionable
Optionable
Beta
1.23

Key Executives

  • Mr. Yossi Carmil (Age 55)
    Founder, CEO & Director
  • Ms. Dana Gerner (Age 55)
    Chief Financial Officer
  • Mr. Ronnen Armon (Age 59)
    Chief Products & Technologies Officer
  • Anat Earon-Heilborn
    VP of Investor Relations
  • Ms. Ayala Berler Shapira
    Gen. Counsel
  • Adam Jaffe
    VP of Global Communications
  • Ms. Osnat Tirosh (Age 53)
    Chief People & Corp. Devel. Officer
  • Mr. Leeor Ben-Peretz (Age 46)
    Chief Strategy Officer
  • Mr. Paul Battaglia
    Sr. VP of Sales for Mobile Forensic Bus. In North America
  • Mr. Ori Nurick
    Exec. VP of Portfolio Strategy













CLBT Stock - Frequently Asked Questions

Should I buy or sell Cellebrite DI stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cellebrite DI in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CLBT shares.
View CLBT analyst ratings
or view top-rated stocks.

What is Cellebrite DI's stock price forecast for 2023?

7 brokers have issued 12 month price targets for Cellebrite DI's shares. Their CLBT share price forecasts range from $6.00 to $10.50. On average, they predict the company's stock price to reach $8.83 in the next year. This suggests a possible upside of 94.1% from the stock's current price.
View analysts price targets for CLBT
or view top-rated stocks among Wall Street analysts.

How have CLBT shares performed in 2022?

Cellebrite DI's stock was trading at $8.02 at the start of the year. Since then, CLBT stock has decreased by 43.3% and is now trading at $4.55.
View the best growth stocks for 2022 here
.

Are investors shorting Cellebrite DI?

Cellebrite DI saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 1,490,000 shares, an increase of 5.7% from the October 31st total of 1,410,000 shares. Based on an average daily trading volume, of 120,300 shares, the short-interest ratio is currently 12.4 days. Currently, 4.2% of the shares of the company are sold short.
View Cellebrite DI's Short Interest
.

When is Cellebrite DI's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023.
View our CLBT earnings forecast
.

What guidance has Cellebrite DI issued on next quarter's earnings?

Cellebrite DI issued an update on its FY 2022 earnings guidance on Friday, November, 18th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $270.00 million-$285.00 million, compared to the consensus revenue estimate of $275.08 million.

What is Cellebrite DI's stock symbol?

Cellebrite DI trades on the NASDAQ under the ticker symbol "CLBT."

Who are Cellebrite DI's major shareholders?

Cellebrite DI's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Light Street Capital Management LLC (3.51%), Phoenix Holdings Ltd. (3.14%), Greenhaven Road Investment Management L.P. (1.83%), ARK Investment Management LLC (0.22%), State Street Corp (0.13%) and Serengeti Asset Management LP (0.07%).

How do I buy shares of Cellebrite DI?

Shares of CLBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cellebrite DI's stock price today?

One share of CLBT stock can currently be purchased for approximately $4.55.

How much money does Cellebrite DI make?

Cellebrite DI (NASDAQ:CLBT) has a market capitalization of $862.90 million and generates $246.25 million in revenue each year. The company earns $71.40 million in net income (profit) each year or $0.82 on an earnings per share basis.

How many employees does Cellebrite DI have?

The company employs 900 workers across the globe.

How can I contact Cellebrite DI?

Cellebrite DI's mailing address is Four Embarcadero Center Suite 2100, SAN FRANCISCO CA, 94111. The official website for the company is www.cellebrite.com. The company can be reached via phone at 415-780-9981, via email at investors@cellebrite.com, or via fax at 972-3924-7104.

This page (NASDAQ:CLBT) was last updated on 11/28/2022 by MarketBeat.com Staff